Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Oncopeptides AB

Closing information (x1000 EUR)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 3,271 Less Arrow 751 More Arrow 11,567
Financial expenses 521 Less Arrow 79 More Arrow 93
Earnings before taxes -22,391 Less Arrow -30,344 Less Arrow -138,984
EBITDA -21,846 Less Arrow -29,849 Less Arrow -136,850
Total assets 21,483 More Arrow 34,626 More Arrow 42,963
Current assets 18,286 More Arrow 32,712 More Arrow 40,322
Current liabilities 4,049 More Arrow 7,474 More Arrow 22,025
Equity capital 5,117 More Arrow 26,445 Less Arrow 20,619
- share capital 947 Less Arrow 942 Less Arrow 818
Employees (average) 52 More Arrow 57 More Arrow 229

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 23.8% More Arrow 76.4% Less Arrow 48.0%
Turnover per employee 63 Less Arrow 13 More Arrow 51
Profit as a percentage of turnover -684.5% Less Arrow -4040.5% More Arrow -1201.6%
Return on assets (ROA) -101.8% More Arrow -87.4% Less Arrow -323.3%
Current ratio 451.6% Less Arrow 437.7% Less Arrow 183.1%
Return on equity (ROE) -437.6% More Arrow -114.7% Less Arrow -674.1%
Change turnover 2,518 Less Arrow -9,879 More Arrow 11,567
Change turnover % 334% Less Arrow -93%
Chg. No. of employees -5 Less Arrow -172 More Arrow 47
Chg. No. of employees % -9% Less Arrow -75% More Arrow 26%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.